Hyderabad, India-based Dr. Reddy's Laboratories Ltd., and Prestige BioPharma Ltd., a Singapore-based firm, entered into an exclusive partnership for the supply and commercialization of the latter's proposed Trastuzumab biosimilar, in select countries. Trastuzumab (HD201) is a proposed biosimilar to Roche’s Herceptin and can be prescribed for the treatment of HER2...
Dr. Reddy’s Laboratories Shuffles Top Management
With the North America head Umang Vora parting ways with the Hyderabad-based drug maker, Alok Sonig has been appointed to replace him. Sonig had worked for Bristol-Meyers to drive its commercial excellence and business model innovation functions at Princeton, New Jersey, before moving to Dr. Reddy’s. Currently he is responsible...